Roger P. Leng
Edmonton, AB T6G2S2, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Targeting mutant p53 in cancer: from mechanistic insights to therapeutic strategies.
Journal: Cellular & molecular biology letters
Published: October 06, 2025
Digging Through the Complexities of Immunological Approaches in Emerging Osteosarcoma Therapeutics: A Comprehensive Narrative Review with Updated Clinical Trials.
Journal: Biomedicines
Published: January 22, 2025
Targeting p53 for immune modulation: Exploring its functions in tumor immunity and inflammation.
Journal: Cancer letters
Published: January 16, 2025
METTL3-Mediated N6-Methyladenosine Ferroptosis in Sepsis-Associated Acute Lung Injury - A Narrative Review.
Journal: Frontiers in bioscience (Landmark edition)
Published: November 20, 2024
How MicroRNAs Command the Battle against Cancer.
Journal: International journal of molecular sciences
Published: April 24, 2024
The SWIB/MDM2 motif of UBE4B activates the p53 pathway.
Journal: Molecular therapy. Nucleic acids
Published: September 14, 2022
DNA damage response revisited: the p53 family and its regulators provide endless cancer therapy opportunities.
Journal: Experimental & molecular medicine
Published: June 05, 2022
The Role of N6-Methyladenosine in the Promotion of Hepatoblastoma: A Critical Review.
Journal: Cells
Published: February 28, 2022
Regulation of the tumor suppressor PTEN in triple-negative breast cancer.
Journal: Cancer letters
Published: September 20, 2021
p63, a key regulator of Ago2, links to the microRNA-144 cluster.
Journal: Cell death & disease
Published: September 09, 2021
Last Updated: 09/26/2026